EirGen Pharma Ltd. - Product Pipeline Review - 2013
Published: Dec-2013 | Format: PDF | Global Markets Direct | Number of pages: 20 | Code: MRS - 994
Global Market Directs pharmaceuticals report, EirGen Pharma Ltd. Product Pipeline Review 2013 provides data on the EirGen Pharma Ltd.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Directs proprietary databases, EirGen Pharma Ltd.s corporate website, SEC filings, investor presentations and featured press releases, both from EirGen Pharma Ltd. and industry-specific third party sources, put together by Global Markets Directs team.
EirGen Pharma Ltd. Brief EirGen Pharma Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
Review of current pipeline of EirGen Pharma Ltd. human therapeutic division.
Overview of pipeline therapeutics across various therapy areas.
Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Product profiles for late stage and clinical stage products of EirGen Pharma Ltd. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
Recent updates of the EirGen Pharma Ltd.s pipeline in the last quarter.
Key discontinued and dormant projects.
Latest news and deals relating to the products.
Reasons to buy
Evaluate EirGen Pharma Ltd.s strategic position with total access to detailed information on its product pipeline.
Assess the growth potential of EirGen Pharma Ltd. in its therapy areas of focus.
Identify new drug targets and therapeutic classes in the EirGen Pharma Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
Exploit collaboration and partnership opportunities with EirGen Pharma Ltd..
Avoid Intellectual Property Rights related issues.
Explore the dormant and discontinued projects of EirGen Pharma Ltd. and identify potential opportunities in those areas.
Table of Contents 2
List of Tables 3
List of Figures 3
EirGen Pharma Ltd. Snapshot 4
EirGen Pharma Ltd. Overview 4
Key Information 4
Key Facts 4
EirGen Pharma Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
EirGen Pharma Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
EirGen Pharma Ltd. - Pipeline Products Glance 9
EirGen Pharma Ltd. - Late Stage Pipeline Products 9
Pre-Registration Products/Combination Treatment Modalities 9
EirGen Pharma Ltd. - Unknown Stage Pipeline Products 10
Unknown Products/Combination Treatment Modalities 10
EirGen Pharma Ltd. - Drug Profiles 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Product Description 12
Mechanism of Action 12
R&D Progress 12
Product Description 13
Mechanism of Action 13
R&D Progress 13
Product Description 14
Mechanism of Action 14
R&D Progress 14
Product Description 15
Mechanism of Action 15
R&D Progress 15
EirGen Pharma Ltd. - Pipeline Analysis 16
EirGen Pharma Ltd. - Pipeline Products by Therapeutic Class 16
EirGen Pharma Ltd. - Pipeline Products by Molecule Type 17
EirGen Pharma Ltd. - Locations And Subsidiaries 18
Head Office 18
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
List of Tables
EirGen Pharma Ltd., Key Information 4
EirGen Pharma Ltd., Key Facts 4
EirGen Pharma Ltd. - Pipeline by Indication, 2013 6
EirGen Pharma Ltd. - Pipeline by Stage of Development, 2013 7
EirGen Pharma Ltd. - Monotherapy Products in Pipeline, 2013 8
EirGen Pharma Ltd. - Pre-Registration, 2013 9
EirGen Pharma Ltd. - Unknown, 2013 10
EirGen Pharma Ltd. - Pipeline by Therapeutic Class, 2013 16
EirGen Pharma Ltd. - Pipeline by Molecule Type, 2013 17
Inquiry For Buying
COVID-19 Pandemic Impacts
Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.
Medical QMS Software-United States Market Status and Trend Report 2020-2025
Medical QMS Software-India Market Status and Trend Report 2020-2025
Medical QMS Software-China Market Status and Trend Report 2020-2025
Medical QMS Software-Asia Pacific Market Status and Trend Report 2020-2025
Medical QMS Software-EMEA Market Status and Trend Report 2020-2025View More
Along with 7 Realme Products, Realme Buds Q TWS Earbuds Will Also be Launched on May 25
Realme has added an addition in its product portfolio, i.e., the completely wireless headset Realm
iOS 13.5 and iPaDOS 13.5 Released by Apple Includes Features Relevant with COVID-19
Apple released its iOS 13.5 and iPadOS 13.5 that includes features that are appropriate for post-C
Canada and the US will no Longer Find Talc-based Johnson & Johnson Baby Powder
On Tuesday, Johnson Johnson made an official announcement that talc-based Johnsons Baby Powder wi
Foreign Investments being pulled out from Asian Countries
The world is facing one of deadliest recession of all times and amidst all these the foreign inves
Claims from the British American Tobacco that Coronavirus Vaccine Prepared by them is Ready for Human Trials
Every other region and institutions are trying out their level hard to find vaccination for COVID-